View Post

Prepare to Prevent the Next “Disease X”

In COVID-19, Latest News by Precision Vaccinations

‘Vaccines are at the heart of how modern societies counter infectious disease threats. They are our most potent tool against pandemic risks and will be critical to any future response,” wrote Dr. Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI).
“The faster an effective vaccine is developed, the faster an incipient pandemic can be contained and controlled.”
Excerpts for Dr. Hatchett’s December 2021 post are inserted below:
“The X in “Disease X”  stands for everything we don’t know. 

View Post

Are One-Dose HPV Vaccinations Becoming the New Normal?

In COVID-19, Latest News by Precision Vaccinations

The U.K.’s Joint Committee on Vaccination and Immunisation (JCVI) has been considering a potential move to authorize just one dose of the HPV vaccine for several years. 
Indeed, the JCVI was aware of the potential for one dose as far back as 2018.
The committee agreed in February 2022 that there is now enough clinical evidence to advise a change in the schedule from two doses of 4-valent HPV vaccine to one dose in the routine adolescent program for those up to 14 years of age.